MoneyWorks4Me

A decrease in the sales to Rs. 2820.00 millions was observed for the quarter ended December 2022. The sales stood at Rs. 3090.00 millions during the similar quarter previous year.The Net Loss for the quarter ended December 2022 is Rs. -550.00 millions as compared to Net Loss of Rs. -670.00 millions of corresponding quarter ended December 2021Operating Profit saw a handsome growth to 440.00 millions from 180.00 millions in the quarter ended December 2022.


(Rs. in Million)


  Quarter ended Year to Date Year ended
  202212 202112 % Var 202212 202112 % Var 202203 202103 % Var
Sales 2820.00 3090.00 -8.74 7810.00 8980.00 -13.03 13720.00 9870.00 39.01
Other Income 180.00 30.00 500.00 960.00 220.00 336.36 380.00 410.00 -7.32
PBIDT 440.00 180.00 144.44 1380.00 500.00 176.00 2600.00 -970.00 -368.04
Interest 520.00 790.00 -34.18 1710.00 1940.00 -11.86 2730.00 2000.00 36.50
PBDT -80.00 -610.00 -86.89 -830.00 -1440.00 -42.36 -130.00 -4390.00 -97.04
Depreciation 470.00 430.00 9.30 1410.00 1280.00 10.16 1710.00 1840.00 -7.07
PBT -550.00 -1040.00 -47.12 -2240.00 -2720.00 -17.65 -1840.00 -6230.00 -70.47
TAX 0.00 -370.00 0.00 -570.00 -920.00 -38.04 -440.00 -2310.00 -80.95
Deferred Tax 0.00 -370.00 0.00 -570.00 -920.00 -38.04 -490.00 -950.00 -48.42
PAT -550.00 -670.00 -17.91 -1670.00 -1800.00 -7.22 -1400.00 -3920.00 -64.29
Equity 720.00 550.00 30.91 720.00 550.00 30.91 720.00 550.00 30.91
PBIDTM(%) 15.60 5.83 167.85 17.67 5.57 217.35 18.95 -9.83 -292.82
Peers
Company Name CMP
Sun Pharma. Inds. 1842.00
Dr. Reddys Labs. 1161.00
Cipla 1365.00
Lupin 2096.00
Zydus Lifesciences 1119.50
View more..